Loading...
miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease that typically leads to respiratory failure and death within 3–5 years of diagnosis. Sub-pleural pulmonary fibrosis is a pathological hallmark of IPF. Bleomycin treatment of mice is a an established pulmonary fibrosis model. W...
Na minha lista:
| Udgivet i: | Mol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363213/ https://ncbi.nlm.nih.gov/pubmed/28131417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2016.12.017 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|